SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Jefferies Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $62

Jefferies initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy rating and announces Price Target of $62.

Benzinga · 05/18/2020 11:11

Jefferies initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy rating and announces Price Target of $62.